iTeos Therapeutics to Participate in Upcoming U.S. Conferences in September
29 août 2018 07h00 HE
|
iTeos Therapeutics SA
iTeos Therapeutics to Participate in Upcoming U.S. Conferences in September Gosselies, Belgium – August 29, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer...
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer
03 juil. 2018 07h00 HE
|
iTeos Therapeutics SA
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today...
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer
03 juil. 2018 01h00 HE
|
iTeos Therapeutics SA
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today...
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director
27 juin 2018 06h00 HE
|
iTeos Therapeutics SA
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director Two new appointments follow oversubscribed $75...
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director
27 juin 2018 01h00 HE
|
iTeos Therapeutics SA
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director Two new appointments follow oversubscribed $75...
iTeos Therapeutics Completes $75 Million Series B Financing
20 juin 2018 07h00 HE
|
iTeos Therapeutics SA
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative...
iTeos Therapeutics Completes $75 Million Series B Financing
20 juin 2018 01h00 HE
|
iTeos Therapeutics SA
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative...